Pluri (PLUR) EBT Margin (2011 - 2025)

Pluri (PLUR) reported EBT Margin of 3474.75% for Q4 2025, down 179367.0% year-over-year from N/an in Q4 2024, and down 78.83% quarter-over-quarter from 1943.04% in Q3 2025.

Pluri (PLUR) EBT Margin (2011 - 2025) Analysis & Trends

Pluri (PLUR) has 12 years of EBT Margin data on file, last reported at 3474.75% in Q4 2025.

  • EBT Margin for Q4 2025 came in at 3474.75%, down 179367.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1903.36% (up 121611.0% YoY), and the FY2025 annual result was 1740.64%, up 480660.0% from the prior year.
  • EBT Margin declined to 3474.75% in Q4 2025 per PLUR's latest filing, from 1943.04% in the prior quarter.
  • Over five years, EBT Margin peaked at 1314.29% in Q1 2025 and troughed at 344550.0% in Q4 2022.
  • A 4-year average of 27589.06% and a median of 5170.48% in 2023 frame the typical range for EBT Margin.
  • On a YoY basis, EBT Margin climbed as much as 33937952 bps in 2023 and fell as far as 393385 bps in 2023.
  • A 4-year view of EBT Margin shows it stood at 344550.0% in 2022, then soared by 98 bps to 5170.48% in 2023, then jumped by 67 bps to 1681.08% in 2024, then sank by 107 bps to 3474.75% in 2025.
  • Business Quant data shows PLUR's EBT Margin at 3474.75% in Q4 2025, 1943.04% in Q3 2025, and 1722.11% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 6.40%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 41.95%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 -3,474.75%

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,474.75%
Sep 30, 2025 -1,943.04%
Jun 30, 2025 -1,722.11%
Mar 31, 2025 -1,314.29%
Dec 31, 2024 -1,681.08%
Sep 30, 2024 -1,851.53%
Jun 30, 2024 -6,512.50%
Mar 31, 2024 -8,101.41%
Dec 31, 2023 -5,170.48%
Sep 30, 2023 -10,353.70%
Jun 30, 2023 -6,093.69%
Mar 31, 2023 -8,410.34%
Dec 31, 2022 -344,550.00%
Sep 30, 2022 -8,180.46%
Mar 31, 2022 -4,476.50%
Dec 31, 2019 -27,686.96%
Dec 31, 2018 -16,662.00%
Sep 30, 2018 -224,250.00%
Dec 31, 2017 -16,934.00%
Dec 31, 2015 -153.63%